A Study of AK117 in Combination With Azacitidine in Patients With Myelodysplastic Syndromes

Clinical trial NCT06196203 · RECRUITING

Trial details

NCT number: NCT06196203
Sponsor: Akeso
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Higher-risk Myelodysplastic Syndromes

Start date: 2024-02-07
Primary completion: 2026-01-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.